Skip to main content
Top
Published in: Nutrition Journal 1/2011

Open Access 01-12-2011 | Short Report

Relationship of Adiposity and Insulin Resistance Mediated by Inflammation in a Group of Overweight and Obese Chilean Adolescents

Authors: Marcela Reyes, Sheila Gahagan, Erik Díaz, Estela Blanco, Laura Leiva, Lydia Lera, Raquel Burrows

Published in: Nutrition Journal | Issue 1/2011

Login to get access

Abstract

The mild chronic inflammatory state associated with obesity may be an important link between adiposity and insulin resistance (IR). In a sample of 137 overweight and obese Chilean adolescents, we assessed associations between high-sensitivity C-reactive protein (hs-CRP), IR and adiposity; explored sex differences; and evaluated whether hs-CRP mediated the relationship between adiposity and IR. Positive relationships between hs-CRP, IR and 2 measures of adiposity were found. Hs-CRP was associated with waist circumference (WC) in boys and fat mass index (FMI) in girls. Using path analysis, we found that hs-CRP mediated the relationship between adiposity (WC and FMI) and the homeostatic model assessment of insulin resistance (HOMA-IR) (p < 0.05) in both sexes. Our novel finding is that inflammation statistically mediated the well described link between increased adiposity and IR.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cook S, Auinger P, Li C, Ford ES: Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. J Pediatr. 2008, 152 (2): 165-170. 10.1016/j.jpeds.2007.06.004.CrossRefPubMed Cook S, Auinger P, Li C, Ford ES: Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. J Pediatr. 2008, 152 (2): 165-170. 10.1016/j.jpeds.2007.06.004.CrossRefPubMed
2.
go back to reference Steinberger J, Daniels SR: Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation. 2003, 107 (10): 1448-1453. 10.1161/01.CIR.0000060923.07573.F2.CrossRefPubMed Steinberger J, Daniels SR: Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation. 2003, 107 (10): 1448-1453. 10.1161/01.CIR.0000060923.07573.F2.CrossRefPubMed
3.
go back to reference Jensen MD: Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity (Silver Spring). 2006, 14 (Suppl 1): 20S-24S. 10.1038/oby.2006.278.CrossRef Jensen MD: Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity (Silver Spring). 2006, 14 (Suppl 1): 20S-24S. 10.1038/oby.2006.278.CrossRef
4.
go back to reference Hotamisligil GS: Inflammation and metabolic disorders. Nature. 2006, 444 (7121): 860-867. 10.1038/nature05485.CrossRefPubMed Hotamisligil GS: Inflammation and metabolic disorders. Nature. 2006, 444 (7121): 860-867. 10.1038/nature05485.CrossRefPubMed
5.
go back to reference Cartier A, Cote M, Lemieux I, Perusse L, Tremblay A, Bouchard C, Despres JP: Sex differences in inflammatory markers: what is the contribution of visceral adiposity?. Am J Clin Nutr. 2009, 89 (5): 1307-1314. 10.3945/ajcn.2008.27030.CrossRefPubMed Cartier A, Cote M, Lemieux I, Perusse L, Tremblay A, Bouchard C, Despres JP: Sex differences in inflammatory markers: what is the contribution of visceral adiposity?. Am J Clin Nutr. 2009, 89 (5): 1307-1314. 10.3945/ajcn.2008.27030.CrossRefPubMed
6.
go back to reference Thorand B, Baumert J, Doring A, Herder C, Kolb H, Rathmann W, Giani G, Koenig W: Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis. 2006, 184 (1): 216-224. 10.1016/j.atherosclerosis.2005.04.011.CrossRefPubMed Thorand B, Baumert J, Doring A, Herder C, Kolb H, Rathmann W, Giani G, Koenig W: Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis. 2006, 184 (1): 216-224. 10.1016/j.atherosclerosis.2005.04.011.CrossRefPubMed
7.
go back to reference Fernandez JR, Redden DT, Pietrobelli A, Allison DB: Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr. 2004, 145 (4): 439-444. 10.1016/j.jpeds.2004.06.044.CrossRefPubMed Fernandez JR, Redden DT, Pietrobelli A, Allison DB: Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr. 2004, 145 (4): 439-444. 10.1016/j.jpeds.2004.06.044.CrossRefPubMed
8.
go back to reference Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL: CDC growth charts: United States. Adv Data. 2000, 314: 1-27.PubMed Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL: CDC growth charts: United States. Adv Data. 2000, 314: 1-27.PubMed
9.
go back to reference Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics. 1996, 98 (4 Pt 1): 649-658. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics. 1996, 98 (4 Pt 1): 649-658.
10.
go back to reference Schoeller DA: Hydrometry. Human body composition. Edited by: Roche A, Heymsfield S, Lohman TG. 1996, New York: Human Kinetics, 25-43. Schoeller DA: Hydrometry. Human body composition. Edited by: Roche A, Heymsfield S, Lohman TG. 1996, New York: Human Kinetics, 25-43.
11.
go back to reference Van ltallie TB, Yang MU, Heymsfield SB, Funk RC, Boileau RA: Height-normalized indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status. Am J Clin Nutr. 1990, 52 (6): 953-959. Van ltallie TB, Yang MU, Heymsfield SB, Funk RC, Boileau RA: Height-normalized indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status. Am J Clin Nutr. 1990, 52 (6): 953-959.
12.
go back to reference Hu L, Bentler P: Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling. 1999, 6: 1-55. 10.1080/10705519909540118.CrossRef Hu L, Bentler P: Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling. 1999, 6: 1-55. 10.1080/10705519909540118.CrossRef
13.
go back to reference Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB: Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999, 282 (22): 2131-2135. 10.1001/jama.282.22.2131.CrossRefPubMed Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB: Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999, 282 (22): 2131-2135. 10.1001/jama.282.22.2131.CrossRefPubMed
14.
go back to reference Warnberg J, Nova E, Moreno LA, Romeo J, Mesana MI, Ruiz JR, Ortega FB, Sjostrom M, Bueno M, Marcos A: Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr. 2006, 84 (3): 505-512.PubMed Warnberg J, Nova E, Moreno LA, Romeo J, Mesana MI, Ruiz JR, Ortega FB, Sjostrom M, Bueno M, Marcos A: Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr. 2006, 84 (3): 505-512.PubMed
15.
go back to reference Park K, Steffes M, Lee DH, Himes JH, Jacobs DR: Association of inflammation with worsening HOMA-insulin resistance. Diabetologia. 2009, 52 (11): 2337-2344. 10.1007/s00125-009-1486-5.CrossRefPubMed Park K, Steffes M, Lee DH, Himes JH, Jacobs DR: Association of inflammation with worsening HOMA-insulin resistance. Diabetologia. 2009, 52 (11): 2337-2344. 10.1007/s00125-009-1486-5.CrossRefPubMed
16.
go back to reference Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM: Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA. 1994, 91 (11): 4854-4858. 10.1073/pnas.91.11.4854.CrossRefPubMedPubMedCentral Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM: Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA. 1994, 91 (11): 4854-4858. 10.1073/pnas.91.11.4854.CrossRefPubMedPubMedCentral
17.
go back to reference Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW: CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest. 2006, 116 (1): 115-124. 10.1172/JCI24335.CrossRefPubMed Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW: CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest. 2006, 116 (1): 115-124. 10.1172/JCI24335.CrossRefPubMed
18.
go back to reference Wells JC: Sexual dimorphism of body composition. Best Pract Res Clin Endocrinol Metab. 2007, 21 (3): 415-430. 10.1016/j.beem.2007.04.007.CrossRefPubMed Wells JC: Sexual dimorphism of body composition. Best Pract Res Clin Endocrinol Metab. 2007, 21 (3): 415-430. 10.1016/j.beem.2007.04.007.CrossRefPubMed
19.
go back to reference Tarantino G, Colicchio P, Conca P, Finelli C, Di Minno MN, Tarantino M, Capone D, Pasanisi F: Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively?. J Inflamm. 2009, 16 (6): 1-6. Tarantino G, Colicchio P, Conca P, Finelli C, Di Minno MN, Tarantino M, Capone D, Pasanisi F: Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively?. J Inflamm. 2009, 16 (6): 1-6.
20.
go back to reference Patton HM, Yates K, Unalp-Arida A, Behling CA, Huang TT, Rosenthal P, Sanyal AJ, Schwimmer JB, Lavine JE: Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. Am J Gastroenterol. 2010, 105 (9): 2093-102. 10.1038/ajg.2010.152.CrossRefPubMedPubMedCentral Patton HM, Yates K, Unalp-Arida A, Behling CA, Huang TT, Rosenthal P, Sanyal AJ, Schwimmer JB, Lavine JE: Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. Am J Gastroenterol. 2010, 105 (9): 2093-102. 10.1038/ajg.2010.152.CrossRefPubMedPubMedCentral
Metadata
Title
Relationship of Adiposity and Insulin Resistance Mediated by Inflammation in a Group of Overweight and Obese Chilean Adolescents
Authors
Marcela Reyes
Sheila Gahagan
Erik Díaz
Estela Blanco
Laura Leiva
Lydia Lera
Raquel Burrows
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Nutrition Journal / Issue 1/2011
Electronic ISSN: 1475-2891
DOI
https://doi.org/10.1186/1475-2891-10-4

Other articles of this Issue 1/2011

Nutrition Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine